Geneviève Almouzni

Geneviève obtained her PhD in 1988 from the University Pierre and Marie Curie, Paris and carried out postdoctoral research at the NIH, USA characterizing the importance of chromatin for transcriptional regulation using Xenopus as a model system. Almouzni serves as a member of several scientific advisory boards and editorial boards (including Cell, EMBO Journal and Molecular Oncology) and has pioneered many European and international collaborations to promote research in the field of epigenetics. She served as a co-coordinator of the European Network of Excellence EpiGeneSys and, currently, is a co-coordinator of the DEEP LabEx. She was elected Co-Chair of EU-Life in 2016 and Chair in 2018. She has also been awarded several international grants (Human Science Frontier, ERC Advanced Grant).
Her work has been recognized by numerous distinctions and honours, such as the prestigious Officier dans l’Ordre National du Mérite in 2017. She was elected at the French Académie des Sciences in 2013 and received the FEBS/EMBO Women in Science award and the AAAS award the same year. She was nominated vice-chair of the EMBO council in 2014 and European Academy of Cancer Sciences Fellow.